Minimally Invasive Treatment Methods for Pilonidal Disease

Randomized Prospective Comparison of Crystallized Phenol and Platelet Rich Plasma Applications in Treatment of Pilonidal Sinus Disease

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03070028

Enrollment

200

Registered

2017-03-03

Start date

2017-01-01

Completion date

2020-05-01

Last updated

2020-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pilonidal Sinus

Brief summary

Patients with pilonidal sinus disease will be randomised to two groups (crystallised phenol and platelet rich plasma). Sinus healing time, patient satisfaction, complications and recurrence rates will be compared.

Detailed description

Patients with pilonidal sinus disease will be treated by either crystallised phenol or platelet rich plasma application. Treatment results, healing time, postprocedural complications, patient satisfaction and recurrences will be compared.

Interventions

PROCEDUREcrystallised phenol

crystallised phenol will be applied to sinus cavity

PROCEDUREPlatelet rich plasma

platelet rich plasma will be applied to sinus cavity

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Having pilonidal sinus disease * accepting to be involved in the study

Exclusion criteria

* below the age of 18 * having connective tissue disorders * diabetes mellitus * severe anemia

Design outcomes

Primary

Measure	Time frame	Description
healing time	first 1 year of the study	Time to complete closure of the sinus cavity.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026